Table 4.
Year 1 (n = 28) | Year 3 (n = 62) | t-value or X2 (DF) | p-valuea | |
---|---|---|---|---|
Age [mean years (SD)] | 65.1 (11.2) | 65.8 (9.1) | t (88 DF) = − 0.30, | p = 0.761 |
Male [n (%)] | 16 (57%) | 37 (59%) | X2 (1 DF) = 0.05 | p = 0.821 |
UPDRS [mean (SD)] | 16.2 (6.8) | 23.2 (12.0) | t (50.7 DF) = − 2.78 | p = 0.0076 |
Missinga | 0 | 30 | ||
Hoehn and Yahr stage | X2 (2 DF) = 1.75 | p = 0.418 | ||
1 | 5 (18%) | 9 (15%) | ||
2 | 23 (82%) | 23 (37%) | ||
3 | 0 (0%) | 1 (2%) | ||
Missinga | 0 (%) | 29 (47%) | ||
Time since diagnosis | X2 (4 DF) = 9.25 | p = 0.055 | ||
< 1 month | 14 (50%) | 12 (19%) | ||
1–6 months | 4 (14%) | 19 (31%) | ||
6-12 months | 4 (14%) | 8 (13%) | ||
1–2 years | 3 (11%) | 7 (11%) | ||
2+ years | 3 (11%) | 13 (21%) | ||
Missing a | 0 (0%) | 3 (5%) | ||
Time since symptoms | X2 (3 DF) = 9.06 | p = 0.029 | ||
< 1 month | 0 (0%) | 0 (0%) | ||
1–6 months | 5 (18%) | 1 (2%) | ||
6–12 months | 5 (18%) | 11 (18%) | ||
1–2 years | 5 (18 %) | 20 (32%) | ||
2+ years | 13 (46%) | 23 (37%) | ||
Missing a | 0 (0%) | 7 (11%) | ||
Insurance | X2 (2 DF) = 1.14 | p = 0.565 | ||
Medicare | 15 (54%) | 29 (47%) | ||
Blue Cross Blue Shield | 9 (32%) | 18 (29%) | ||
Other | 4 (14%) | 15 (26%) |
aMissing data were excluded from analyses (UPDRS and Hoehn and Yahr were missing from provider referral notes)